ArticleFrontiers in neurology2024

A comparison of natalizumab's effects on SDMT between pediatric-onset and adult-onset multiple sclerosis patients.

Marco Puthenparampil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.